PRKDC and head and neck squamous cell carcinoma: Inhibition of CHK1/2 with AZD7762, inhibition of DNA-PKcs with NU7441 and inhibition of BER with ABT-888 in combination with RT resulted in radiosensitization of radioresistant HNSCC cells, to the extent that they rescued the radioresistant phenotype (Figure 3A).